Eli Lilly CEO talks expanding innovation past obesity drugs Published 2024-01-08 Download video MP4 360p Download video MP4 720p Recommendations 19:20 How Ozempic And Wegovy Accidentally Made Novo Nordisk A $400B Company 12:18 Why Widespread Tech Layoffs Keep Happening Despite A Strong U.S. Economy 07:21 Why Eli Lilly is a top pick to capitalize on GLP-1 drug craze 07:04 Exclusive: How Eli Lilly’s making weight loss drugs more accessible 05:38 Canadian economy has been in borderline recession for the last 6 months: strategist 06:55 Stocks: Reasons to go in on Eli Lilly stock, but avoid Tesla 05:40 Eli Lilly has a lot of innovation that goes beyond obesity drugs: analyst 13:06 Novo Nordisk CEO on Catalent, Ozempic and Wegovy 09:08 The AI dark horse: Why Apple could win the next evolution of the AI arms race 05:35 Billionaire investor Ken Langone: Lilly will be the first trillion dollar drug company in history 33:22 JP Morgan Chief Jamie Dimon on the Dire State of the Global Economy | DealBook Summit 2023 19:09 Novogratz Talks Bitcoin Surge and Ethereum ETF 10:44 Walmart CEO Doug McMillon goes one-on-one with Jim Cramer 05:55 BlackRock Strategist explains what to consider when broadening investments 10:43 Is this the end of Google Search? How the giant could lose its lead 03:24 3-Stock Lunch: AMZN, WBA & LLY 04:14 Eli Lilly CEO David Ricks on GLP-1 and obesity drugs 04:47 Nvidia's AI pathway is not as easy or open to profits as markets assume, says NYU's Damodaran 07:50 Warren Buffett's letter, Berkshire earnings: What to watch 03:58 Eli Lilly hits record high: Here's what investors need to know Similar videos 03:36 Pharmaceutical giant Eli Lilly launches new website to expand patient access to key medicines 06:13 Obesity weight loss market will remain a duopoly between Novo Nordisk and Eli Lilly: BofA’S Meacham 23:13 Why Novo Nordisk’s Drugs Are Anti-Obesity Game-Changers: CNBC Healthy Returns Summit 2023 05:24 Novo Nordisk Winning in Rivalry With Lilly, CEO Says 14:05 Understanding the Impact of Social Bias on Healthcare Inequities 05:01 Eli Lilly CEO weighs in on Q4 revenue miss 07:12 Ozempic is a game-changer. Here’s how it works. 05:45 Lilly's Lechleiter Says Emerging Markets to Help Growth 02:24 Eli Lilly, Roche leaders discuss future for health innovations 03:43 Eli Lilly's valuation is justified when you look at the growth profile, says UBS' Bristow 02:49 U.S. doctors are 'wowed' by Novo Nordisk's weight-loss drug data, analyst says 27:36 Are We In A Weight-Loss Revolution? 06:02 Ricks on the State of Eli Lilly and Co. & What's Next 04:23 Two bullish calls on Eli Lilly 03:45 Michele’s Journey Overcoming Challenges to Advocate for Her Own Health 55:16 Day 68⚡️ Eli Lilly’s Obesity Medication Looks Poised to Become a $100 Billion a Year Drug 08:39 Lilly's big investment in Lebanon More results